In 1985, Professors Sir Marc Feldmann and Sir Ravinder Maini identified Tumour Necrosis Factor alpha (TNFα) as a key component in diseases of inflammation. They suggested treatment for such diseases could improve by blocking TNFα. This discovery led to decades...